Skip to main content
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1987 Apr;68(2):215–223.

In-vitro teratogenicity of retinoids.

C E Steele, R Marlow, J Turton, R M Hicks
PMCID: PMC2013012  PMID: 3580281

Abstract

Mid-gestation rat conceptuses were cultured for 48 h in serum containing the retinoids all-trans-retinoic acid (TRA), 13-cis-retinoic acid (13-CRA), etretinate (ETR), etretin or one of six retinamides at concentrations ranging from 0.5 to 400 micrograms/ml. TRA was toxic at a concentration of 0.5 microgram/ml. 13-CRA and etretin caused abnormal development at 1.0 microgram/ml. However, the six retinamides were less toxic and adverse developmental effects were only evident at concentrations of 50 or 100 micrograms/ml. ETR was without effect at 100 micrograms/ml, the highest dose level of this compound tested. In vivo, TRA, 13-CRA and ETR are highly teratogenic. In this culture system, TRA and 13-CRA caused abnormal development at very low concentrations but in contrast, ETR was non-toxic at 100 micrograms/ml. Therefore these findings indicate that in vivo, maternal pharmacokinetics, and bioactivation in particular, play a major role in inducing abnormal development. Cis/trans isomerization was not a major determinant of toxicity. However, there appeared to be a relationship between abnormal development and the actual or estimated pKa values of the 10 retinoids tested.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollag W. Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet. 1983 Apr 16;1(8329):860–863. doi: 10.1016/s0140-6736(83)91394-6. [DOI] [PubMed] [Google Scholar]
  2. Elias P. M., Williams M. L. Retinoids, cancer, and the skin. Arch Dermatol. 1981 Mar;117(3):160–168. [PubMed] [Google Scholar]
  3. Goulding E. H., Pratt R. M. Isotretinoin teratogenicity in mouse whole embryo culture. J Craniofac Genet Dev Biol. 1986;6(2):99–112. [PubMed] [Google Scholar]
  4. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  5. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T., Curry C. J., Fernhoff P. M., Grix A. W., Jr, Lott I. T. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837–841. doi: 10.1056/NEJM198510033131401. [DOI] [PubMed] [Google Scholar]
  6. Morriss G. M., Steele C. E. Comparison of the effects of retinol and retinoic acid on postimplantation rat embryos in vitro. Teratology. 1977 Feb;15(1):109–119. doi: 10.1002/tera.1420150115. [DOI] [PubMed] [Google Scholar]
  7. Morriss G. M., Steele C. E. The effect of excess vitamin A on the development of rat embryos in culture. J Embryol Exp Morphol. 1974 Oct;32(2):505–514. [PubMed] [Google Scholar]
  8. Morriss G. M., Thomson A. D. Letter: Vitamin A and rat embryos. Lancet. 1974 Oct 12;2(7885):899–900. doi: 10.1016/s0140-6736(74)91236-7. [DOI] [PubMed] [Google Scholar]
  9. New D. A., Coppola P. T., Cockroft D. L. Comparison of growth in vitro and in vivo of post-implantation rat embryos. J Embryol Exp Morphol. 1976 Aug;36(1):133–144. [PubMed] [Google Scholar]
  10. New D. A. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev Camb Philos Soc. 1978 Feb;53(1):81–122. doi: 10.1111/j.1469-185x.1978.tb00993.x. [DOI] [PubMed] [Google Scholar]
  11. Rosa F. W., Wilk A. L., Kelsey F. O. Teratogen update: vitamin A congeners. Teratology. 1986 Jun;33(3):355–364. doi: 10.1002/tera.1420330315. [DOI] [PubMed] [Google Scholar]
  12. Sporn M. B., Roberts A. B. Role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983 Jul;43(7):3034–3040. [PubMed] [Google Scholar]
  13. Steele C. E. Human serum as a culture medium for rat embryos. Experientia. 1985 Dec 15;41(12):1601–1603. doi: 10.1007/BF01964829. [DOI] [PubMed] [Google Scholar]
  14. Steele C. E., New D. A. Serum variants causing the formation of double hearts and other abnormalities in explanted rat embryos. J Embryol Exp Morphol. 1974 Jun;31(3):707–719. [PubMed] [Google Scholar]
  15. Steele C. E., Trasler D. G., New D. A. An in vivo/in vitro evaluation of the teratogenic action of excess vitamin A. Teratology. 1983 Oct;28(2):209–214. doi: 10.1002/tera.1420280209. [DOI] [PubMed] [Google Scholar]
  16. Willhite C. C., Dawson M. I., Williams K. J. Structure-activity relationships of retinoids in developmental toxicology. I. Studies on the nature of the polar terminus of the vitamin A molecule. Toxicol Appl Pharmacol. 1984 Jul;74(3):397–410. doi: 10.1016/0041-008x(84)90293-x. [DOI] [PubMed] [Google Scholar]
  17. Willhite C. C., Shealy Y. F. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids. J Natl Cancer Inst. 1984 Mar;72(3):689–695. [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES